EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Meta-Inflammation in Type 2 Diabetes Mellitus: Theoretical, Methodological, and Clinical Aspects

Yulia Zhuravleva iD, Evgenii Gusev iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27198891 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Yulia Zhuravleva und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Immunology and Physiology, Ural Branch of the Russian Academy of Sciences, 620078 Ekaterinburg, Russia. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Inflammation. Die Arbeit nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institute of Immunology and Physiology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Currently, there is no doubt that insulin resistance (IR) in prediabetes and type 2 diabetes mellitus (T2DM) is associated with chronic systemic metabolic inflammation (SMI). SMI is typically considered a form of low-grade systemic inflammation (LGSI). At the same time, one cannot rule out the possibility of the transformation of LGSI into more pronounced forms of chronic systemic inflammation (ChSI), typical of systemic autoimmune diseases and characterized by a high severity of systemic inflammatory response (SIR). The aim of this research is to assess the pathogenetic role of SMI as a general pathological process in the pathogenesis of prediabetes and T2DM, as well as differentiating SMI into LGSI and ChSI. The study included two main groups—T2DM (n = 65) and prediabetes (n = 24)—as well as three control groups of healthy individuals of different ages (n = 50, n = 89, and n = 22). In the patients of the main groups, metabolic syndrome (MetS) was diagnosed in accordance with the American Heart Association criteria, and metabolic indices (HOMA-IR, HOMA-islet, and TyG) were calculated. The levels of C-reactive protein (CRP) and cytokines (TNFα, IL-6, IL-8, and IL-10) were determined in blood plasma as SIR parameters, and the levels of cortisol (690 nmol/L or 250 and >500 ng/mL), and troponin I (>0.2 ng/mL) were used as additional SMI criteria. Based on molecular inflammatory markers, the ChSI and LGSI scales were calculated using the authors’ original method. SMI in T2DM and prediabetes manifested itself as both LGSI (in 57% of cases in T2DM and 46% in prediabetes) and ChSI (in 18.5% of cases in T2DM and 8.3% in prediabetes). The verification of SMI based on the frequently used criterion of CRP levels above 3 mg/L turned out to be ineffective in our study (this criterion was detected in the control groups in 24–45%). Therefore, we used CRP > 10 mg/L in combination with cytokines as the SIR criterion. Additionally, we identified the SMI criteria: D-dimer > 250 ng/mL in 27.7% of T2DM and 0% in the control groups and prediabetes; cortisol 15.4% in T2DM and 8.3% in prediabetes; and troponin I 7.7% in T2DM and 4.2% in prediabetes. SMI (LGSI and ChSI) develops in the majority of patients with prediabetes (54.1%) and T2DM (75.4%). To assess SMI, it is advisable to use the integral SIR criteria in combination with the markers of chronic stress, tissue damage, and coagulopathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2InflammationHumansFemalePrediabetic StateInsulin ResistanceMaleCytokinesMiddle AgedC-Reactive ProteinMetabolic SyndromeBiomarkersAdultAged

Stichwörter der Autor:innen

chronic systemic inflammationlow-grade systemic inflammationmetabolic syndromeprediabetessystemic metabolic inflammationtype 2 diabetes mellitus

Substanzen

CytokinesC-Reactive ProteinBiomarkers

Autor:innen und Institutionen

  • Institute of Immunology and Physiology, Ural Branch of the Russian Academy of Sciences, 620078 Ekaterinburg, Russia.

ORCID-Profile: Yulia Zhuravleva, Evgenii Gusev

Förderung

  • Institute of Immunology and Physiology

Zitieren

APA

Zhuravleva, Y., & Gusev, E. (2026). Meta-Inflammation in Type 2 Diabetes Mellitus: Theoretical, Methodological, and Clinical Aspects. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27198891

Vancouver

Zhuravleva Y, Gusev E. Meta-Inflammation in Type 2 Diabetes Mellitus: Theoretical, Methodological, and Clinical Aspects. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27198891

BibTeX
@article{Zhuravleva2026,
  author = {Zhuravleva, Yulia and Gusev, Evgenii},
  title = {Meta-Inflammation in Type 2 Diabetes Mellitus: Theoretical, Methodological, and Clinical Aspects},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27198891}
}
Kostenlos starten →